Use of ‘Elf Bar’ among youth and young adults who currently vape in England: cross-sectional associations with demographics, dependence indicators and reasons for use
Abstract
Background and aims: Elf Bar is currently the leading e-cigarette (vape) brand in Great Britain. This study examined youth and young adults’ use of Elf Bar, socio-demographic characteristics and dependence indicators and reasons for use over other brands. Design: Cross-sectional survey. Setting and participants: Online 2022 International Tobacco Control Project Youth Tobacco and Vaping Survey (N = 1355 16–29-year-olds in England who had vaped in the past 30 days). Measurements: Currently using Elf Bar most often (versus other brands) and associations with: socio-demographics, owning a vaping device, dependence indicators and reasons for brand choice. Logistic regressions were used. Findings: Among 16–29-year-olds who vaped in the past 30 days, 48.4% (n = 732) reported Elf Bar as the brand they used most often. Among 16–17-year-olds, 40.7% used Elf Bar over other brands; this was lower than among 18–19-year-olds (60.1%) and 20–29-year-olds (47.4%) (P ≤ 0.002). Using Elf Bar over other brands was higher among those who were female (55.2 versus 41.5% male), identified as White (53.1 versus 30.9% other/mixed), a student (54.5 versus 44.3% not), did not own a vape (66.7 versus 44.4% who did) and typically vaped 5–8 hours after waking (62.7 versus 36.8% within 5 min) (P ≤ 0.044). Most who vaped but had never smoked used Elf Bar (64.3%), although use did not significantly differ from those who currently (45.4%), formerly (42.3%) or experimentally (48.7%) smoked (all P ≥ 0.060).…
Read the paper
Related studies
- Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary
- Comparative effects of e-cigarette smoking on periodontal status, salivary pH, and cotinine levels
- Association between exposure to environmental pollutants and increased oral health risks, a comprehensive review
- Influence of gestational window on offspring vascular health in rodents with in utero exposure to electronic cigarettes
- Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
- Nicotine in electronic cigarettes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.